Hyaluronan-enriched transfer medium in routine clinical practice: a retrospective cohort study showing no improvement in pregnancy outcomes among predominantly frozen embryo transfer cycles
4 affiliations
- 1Department of Histology and Embryology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
- 2Present Address: Independent Researcher, 41050 Kocaeli, Turkey
- 3Department of Histology and Embryology, Faculty of Medicine, Kocaeli University, Umuttepe Campus, 41380 İzmit, Turkey
- 4Assisted Reproduction Unit, Kocaeli University Hospital, Kocaeli, Turkey
Abstract
Purpose: To evaluate the effect of hyaluronan-enriched transfer medium (HETM; EmbryoGlue) on clinical pregnancy rates in a predominantly frozen embryo transfer (FET) cohort and to identify independent predictors of outcome.
Methods: In this retrospective, nonrandomized cohort study, we analyzed 335 embryo transfer cycles at a university-based ART unit (June 2025–April 2026): HETM group (EmbryoGlue, n = 171) vs. control (Irvine NX medium, n = 164). Allocation to transfer medium was based on shared clinical decision-making. The primary outcome was clinical pregnancy rate per cycle. Multivariate logistic regression identified independent predictors.
Results: FET accounted for 87.5% of cycles. Overall clinical pregnancy rate was 56.7% (190/335). Rates were comparable between HETM and control groups (56.7% vs. 56.7%; OR = 1.00, 95% CI 0.65–1.54; p > 0.999). No statistically significant between-group differences were observed in exploratory subgroups, including women aged ≥ 35 years, cycles with two or more previous transfer attempts, and blastocyst transfers (all p > 0.05). Despite a higher proportion of cycles with two or more previous transfer attempts in the HETM group (41.5% vs. 27.4%; p = 0.008), HETM was not an independent predictor of pregnancy (OR = 0.89, 95% CI 0.55–1.46; p = 0.652). FET (OR = 4.32; p < 0.001), blastocyst-stage transfer (OR = 2.96; p < 0.001), and younger age (OR = 0.92 per year; p = 0.001) were independently associated with clinical pregnancy.
Conclusions: HETM use was not associated with higher clinical pregnancy rates in this cohort. Transfer type, embryo stage, and patient age were independently associated with clinical pregnancy. These findings do not provide evidence supporting the routine use of EmbryoGlue in unselected FET populations.
Related
- Parental determinants of blastocyst euploidy in a predominantly recurrent-pregnancy-loss PGT-A cohort: limited predictive value of female age, BMI, AMH and sperm DNA fragmentation
- Molecular Etiology and Mortality Risk Stratification of Non-SARS-CoV-2 Severe Acute Respiratory Infection in a Predominantly Pediatric Cohort: A Retrospective Study From a Tertiary Care Hospital in North India
- Missed opportunities for universal hepatitis C screening in a predominantly hispanic safety-net popaulation: a retrospective cohort study
- Unintended Pregnancies and Breastfeeding Studies during Central Nervous System Drug Development: How Are they Handled, Is There Room for Improvement?: Maintaining the Gap: Pregnancy and Breastfeeding in CNS Clinical Trials.
- Maternal and Perinatal Outcomes in Pregnancies Complicated by Predominantly Benign Ovarian Lesions: A Retrospective Case-Control Study of 305 Pregnancies
BibTeX
@article{filiz2026hyaluronanenriched,
title = {{Hyaluronan-enriched transfer medium in routine clinical practice: a retrospective cohort study showing no improvement in pregnancy outcomes among predominantly frozen embryo transfer cycles}},
author = {Pelin Coştur Filiz and Serdar Filiz},
journal = {Archives of Gynecology and Obstetrics},
year = {2026},
month = oct,
doi = {10.1007/s00404-026-08592-z},
url = {https://doi.org/10.1007/s00404-026-08592-z},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Hyaluronan-enriched transfer medium in routine clinical practice: a retrospective cohort study showing no improvement in pregnancy outcomes among predominantly frozen embryo transfer cycles
AU - Pelin Coştur Filiz
AU - Serdar Filiz
PY - 2026
DA - 2026/10/13
JO - Archives of Gynecology and Obstetrics
DO - 10.1007/s00404-026-08592-z
UR - https://doi.org/10.1007/s00404-026-08592-z
AB - Purpose: To evaluate the effect of hyaluronan-enriched transfer medium (HETM; EmbryoGlue) on clinical pregnancy rates in a predominantly frozen embryo transfer (FET) cohort and to identify independent predictors of outcome. Methods: In this retrospective, nonrandomized cohort study, we analyzed 335 embryo transfer cycles at a university-based ART unit (June 2025–April 2026): HETM group (EmbryoGlue, n = 171) vs. control (Irvine NX medium, n = 164). Allocation to transfer medium was based on shared clinical decision-making. The primary outcome was clinical pregnancy rate per cycle. Multivariate logistic regression identified independent predictors. Results: FET accounted for 87.5% of cycles. Overall clinical pregnancy rate was 56.7% (190/335). Rates were comparable between HETM and control groups (56.7% vs. 56.7%; OR = 1.00, 95% CI 0.65–1.54; p > 0.999). No statistically significant between-group differences were observed in exploratory subgroups, including women aged ≥ 35 years, cycles with two or more previous transfer attempts, and blastocyst transfers (all p > 0.05). Despite a higher proportion of cycles with two or more previous transfer attempts in the HETM group (41.5% vs. 27.4%; p = 0.008), HETM was not an independent predictor of pregnancy (OR = 0.89, 95% CI 0.55–1.46; p = 0.652). FET (OR = 4.32; p < 0.001), blastocyst-stage transfer (OR = 2.96; p < 0.001), and younger age (OR = 0.92 per year; p = 0.001) were independently associated with clinical pregnancy. Conclusions: HETM use was not associated with higher clinical pregnancy rates in this cohort. Transfer type, embryo stage, and patient age were independently associated with clinical pregnancy. These findings do not provide evidence supporting the routine use of EmbryoGlue in unselected FET populations.
SN - 0932-0067
SN - 1432-0711
ER -